9734 Federal Register / Vol. 80, No. 36 / Tuesday, February 24, 2015 / Notices 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: February 17, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–03687 Filed 2–23–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2015–N–0012] 

Partnership To Develop the Branded 

Food Products Database for Public 

Health (R01) 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of grant funds for the 

support of the Agricultural Technology 

Innovation Partnership’s (ATIP) 

Branded Food Products Database for 

Public Health. ATIP, in conjunction 

with the U.S. Department of Agriculture 

(USDA) Agricultural Research Service 

(ARS) and the International Life Science 

Institute North America (ILSI North 

America), has established a publicprivate partnership to enhance the 

public’s health. The Office of Foods and 

Veterinary Medicine (OFVM) has grant 

funds available to help support ATIP 

consolidate food composition data from 

manufacturers. OFVM’s goal is to 

monitor the sodium content of branded 

foods and to make nutrient composition 

data available to the public. 

DATES: Important dates are as follows: 

1. The application due date is April 

2, 2015. 

2. The anticipated start date is May 

2015. 

3. The opening date is February 13, 

2015. 

4. The expiration date is April 3, 

2015. 

ADDRESSES: For more information, see 

section III of the SUPPLEMENTARY

INFORMATION section of this notice. 

FOR FURTHER INFORMATION CONTACT: 

Claudine Kavanaugh, Office of Foods 

and Veterinary Medicine, 10903 New 

Hampshire Ave., Silver Spring, MD 

20993, 301–796–4647; or Vieda 

Hubbard, Division of Acquisition 

Support and Grants, Food and Drug 

Administration, 5630 Fishers Lane 

(HFA–500), Rockville, MD 20857, 240– 

402–7588. 

For more information on this funding 

opportunity announcement (FOA) and 

to obtain detailed requirements, please 

refer to the full FOA. 

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description 

RFA–FD–15–005 

93.103 

A. Background 

OFVM is interested in monitoring the 

sodium content of branded foods in the 

U.S. marketplace. Knowing the nutrient 

profile of branded foods is critical to 

FDA’s work and to the public’s health. 

Public health experts have linked 

excessive sodium consumption to 

hypertension, cardiovascular disease, 

and other chronic diseases. A database 

that reflects the sodium content of foods 

will help OFVM research strategies 

regarding sodium reduction and help 

the public maintain healthy diets. 

OFVM has funds available for ATIP to 

compile compositional data for branded 

foods for the public’s benefit. ATIP, 

through ILSI North America and USDA, 

has experience engaging the private 

sector and expertise compiling brand 

data. With OFVM’s fiscal contribution, 

ATIP will be able to build upon USDA’s 

National Nutrient Database—widely 

recognized as the gold standard for food 

compositional data—in a timely fashion. 

ATIP’s database will reflect the breadth 

and depth of the nation’s food supply 

and will facilitate nutrition analysis and 

research that otherwise may not be 

possible. 

The research community, healthcare 

professionals, the food industry, and 

policymakers will use ATIP’s database. 

For example, drafters of the National 

Health and Nutrition Examination 

Survey will be able to more accurately 

characterize food selection and sodium 

consumption for Americans. Medical 

researchers will be able to better link 

sodium intake to measures of chronic 

diseases. Food manufacturers will be 

able to compare information to improve 

product formulations. Policy-making 

bodies will be able to develop better 

guidelines that will promote public 

health. Ultimately, having more robust 

sodium data available will allow FDA to 

develop targeted sodium reduction 

strategies and the public to better 

monitor sodium intake. 

B. Research Objectives 

ATIP will compile compositional data 

for branded foods for the public’s 

benefit. The database will include food 

group information on branded foods and 

branded restaurant food products. ATIP 

will manage a large volume of datestamped branded product information 

to link food intake and nutrient 

composition to dietary patterns 

recommendations. ATIP will collect and 

publish comprehensive food 

compositional data, including sodium 

content, in a timely fashion. 

C. Eligibility Information 

This grant is available solely for ATIP. 

Through ILSI North America and USDA, 

respectively, ATIP has existing 

relationships with industry and years of 

food compositional data upon which 

ATIP can build. ATIP has already 

demonstrated that its database can 

effectively manage a large volume of 

date-stamped branded product 

information. Compiling additional 

compositional data for branded foods 

will allow FDA to link sodium intake 

and composition data to dietary patterns 

recommendations more efficiently. 

II. Award Information/Funds Available 

A. Award Amount 

OFVM has $35,000 available for a 

single award to a single grantee—ATIP. 

B. Length of Support 

This grant is available for 1 year from 

the start date. 

III. Electronic Application, 

Registration, and Submission 

Only electronic applications will be 

accepted. To submit an electronic 

application in response to this FOA, 

applicant should first review the full 

announcement. (FDA has verified the 

Web site addresses throughout this 

document, but FDA is not responsible 

for any subsequent changes to the Web 

sites after this document publishes in 

the Federal Register.) For all 

electronically submitted applications, 

the following steps are required. 

• Step 1: Obtain a Dun and Bradstreet 

(DUNS) Number 

• Step 2: Register With System for 

Award Management (SAM) 

• Step 3: Obtain Username & Password 

• Step 4: Authorized Organization 

Representative (AOR) Authorization 

• Step 5: Track AOR Status 

• Step 6: Register With Electronic 

Research Administration (eRA) 

Commons 

Steps 1 through 5, in detail, can be 

found at http://www07.grants.gov/

applicants/organization_

registration.jsp. Step 6, in detail, can be 

found at https://commons.era.nih.gov/

commons/registration/

registrationInstructions.jsp. After you 

have followed these steps, submit 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 36 / Tuesday, February 24, 2015 / Notices 9735 

electronic applications to: http://

www.grants.gov. 

Dated: February 10, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–03690 Filed 2–23–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications/

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Centers of 

Cancer Nanotechnology Excellence (CCNE). 

Date: March 31–April 2, 2015 

Time: 5:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda North Marriott Hotel and 

Conference Center; 5701 Marinelli Road; 

North Bethesda, MD 20852. 

Contact Person: Jeffrey E. DeClue, Ph.D.; 

Scientific Review Officer; Research 

Technology and Contract Review Branch; 

Division of Extramural Activities; National 

Cancer Institute; 9609 Medical Center Drive, 

Room 7W238; Bethesda, MD 20892–9750; 

240–276–6371; decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Omnibus 

R03 & R21 SEP–6. 

Date: April 10, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove; 9609 Medical Center Drive, Room 

7W030; Rockville, MD 20850; (Telephone 

Conference Call). 

Contact Person: Caron A. Lyman, Ph.D. 

Chief, Scientific Review Officer; Research 

Programs Review Branch; Division of 

Extramural Activities; National Cancer 

Institute, NIH; 9609 Medical Center Drive, 

Room 7W126; Bethesda, MD 20892–9750; 

240–276–6348; lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Molecular 

and Cellular Characterization of ScreenDetected Lesions. 

Date: April 13, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center; 5701 Marinelli Road; 

North Bethesda, MD 20852. 

Contact Person: Caron A. Lyman, Ph.D.; 

Chief, Scientific Review Officer; Research 

Programs Review Branch; Division Of 

Extramural Activities; National Cancer 

Institute, NIH; 9609 Medical Center Drive, 

Room 7W126; Bethesda, MD 20892–9750; 

240–276–6348; lymanc@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 18, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03633 Filed 2–23–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke; Special 

Emphasis Panel Clinical Trials SEP. 

Date: March 5–6, 2015. 

Time: 8:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Palomar, 2121 P Street NW., 

Washington, DC 20037. 

Contact Person: Shanta Rajaram, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS/Neuroscience Center, 

6001 Executive Boulevard, Suite 3208, MSC 

9529, Bethesda, MD 20892–9529, 301–435– 

6033, rajarams@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: February 18, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03638 Filed 2–23–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Small; 

Business: Cancer Drug Development and 

Therapeutics. 

Date: March 16–17, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Infectious Diseases and 

Microbiology. 


tkelley on DSK3SPTVN1PROD with NOTICES